CAT
Caterpillar Inc.
CAT has the edge over REZI overall, supported by stronger modeled upside and stronger fundamentals.
REZI
Resideo Technologies, Inc.
REZI offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
REZI Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Stable | |
| Under pressure |
REZI's profitability is currently healthy, and its cash flow is stable, but its revenue and balance sheet are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
REZI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $17.28 | -19% |
| Current | 12x | $21.46 | — |
| Fair | 15x | $26.98 | +26% |
| Expensive | 26x | $45.86 | +114% |
Historical ranges are pointers, not guarantees.
REZI has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
REZI Forward outlook
There aren't enough analyst estimates for REZI to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over REZI on earnings, with more consistent year-over-year improvement.
REZI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.75 | +$6.45 |
| Q2 2026 | $2.52 | +$8.00 |
| Q1 2026 | -$3.58 | -1293% |
| Q4 2025 | -$3.77 | -718% |
| Q3 2025 | -$4.70 | -523% |
| Q2 2025 | -$5.48 | -564% |
| Q1 2025 | $0.30 | -77% |
| Q4 2024 | $0.61 | -57% |
REZI has returned to profit: it earned $1.75 per share over the past year, after losing money the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over REZI on profitability, with a higher operating margin.
REZI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $727M | -61% |
| Q2 2026 | $2B | +2% |
| Q1 2026 | $1.9B | +8% |
| Q4 2025 | $1.9B | +2% |
| Q3 2025 | $1.9B | +2% |
| Q2 2025 | $1.9B | +22% |
| Q1 2025 | $1.8B | +19% |
| Q4 2024 | $1.9B | +21% |
REZI's revenue is shrinking: $727M last quarter, down 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.9% | +1.6 points |
| Q2 2026 | 6.6% | -2.5 points |
| Q1 2026 | 5.3% | -2.3 points |
| Q4 2025 | 7.4% | -0.4 points |
| Q3 2025 | 8.3% | +1.4 points |
| Q2 2025 | 9.1% | +1.4 points |
| Q1 2025 | 7.7% | -0.9 points |
| Q4 2024 | 7.8% | -1.8 points |
REZI's operating margin was 9.9% last quarter, up 1.6 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over REZI on cash flow, with more consistent year-over-year improvement.
REZI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4M | +$1.6B |
| Q2 2026 | $119M | -34% |
| Q1 2026 | -$181M | -$85M |
| Q4 2025 | $262M | +45% |
| Q3 2025 | -$1.6B | -1379% |
| Q2 2025 | $180M | +134% |
| Q1 2025 | -$96M | -$77M |
| Q4 2024 | $181M | -22% |
REZI's free cash flow has turned positive again: $204M over the past year, against −$1.3B the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over REZI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
REZI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | +4.1% | +6M shares |
| 5 years | +3.7% | +5.4M shares |
| Available history | +25% | +30.8M shares |
REZI has 154M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q1 2024 | $1M |
| Q4 2023 | $13M |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over REZI on leverage, with a lower net debt burden relative to earnings.
REZI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 4.2x | High |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 2.0x | Moderate |
| Q4 2024 | 2.0x | Healthy |
REZI's net debt is about 3.3 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
REZI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.9 | Neutral |
| Stochastic | 36.6 | Neutral |
REZI's weekly RSI is 53 (neutral) and its Stochastic is 37 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
REZI PE vs Industrials Sector
| Metric | REZI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 24x | 49% below |
| PE % | 33 | 58 | 25 pts below |
REZI has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
REZI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 16% above |
| 20 week MA | $20.5 | 4.9% above |
| 50 week MA | $22.8 | 5.9% below |
| 100 week MA | $20.5 | 4.7% above |
| 200 week MA | $16.9 | 27% above |
REZI has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over REZI on returns for 2026, with the stronger performance.
REZI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.18 | $15.7 | +91% |
| 2021 | $15.7 | $18.2 | +16% |
| 2022 | $18.2 | $11.3 | -38% |
| 2023 | $11.3 | $13.1 | +16% |
| 2024 | $13.1 | $16.3 | +25% |
| 2025 | $16.3 | $25.1 | +53% |
| 2026 YTD | $25.1 | $21.5 | -14% |
REZI has finished higher in five of the last six years, two of them by more than 50%. It's down 14% so far in 2026.